TABLE 1.
Variable | n (%) |
---|---|
Baseline variables | |
Median age: years (range) | 53 (20–86) |
Gender | |
Male | 117 (47.4) |
Female | 130 (52.6) |
Current smoker | 8 (3.2) |
Median smoking pack-year history: years (range) | 0 (0–50) |
Median BMI: kg/m2 (range) | 26.4 (18.6–48.0) |
Median albumin: g/dL (range) | 4.3 (2.4–5.2) |
CCI: median (range) | 0 (0–8) |
ASA | |
2 | 25 (10.1) |
3 | 126 (51.0) |
4 | 3 (1.2) |
NA | 93 (37.7) |
Primary site | |
Appendix | 166 (67.2) |
Colorectal | 51 (20.6) |
Mesothelioma | 22 (8.9) |
Ovarian | 5 (2.0) |
Small bowel | 3 (1.2) |
Median CEA (ng/ml) | 4.0 (0.2–144.0) |
Symptomatic | 99 (40.0) |
Imaging evidence of disease | 212 (85.8) |
Median preoperative PCI | 6 (0–38) |
Prior chemotherapy | 111 (44.9) |
Prior resection | |
None | 62 (25.1) |
Yes without prior CRS-HIPEC | 166 (67.2) |
Yes with prior CRS-HIPEC | 19 (7.7) |
Operative variables | |
PCI: median (range) | 14 (0–29) |
Median operative time: min (range) | 403.5 (196–799) |
Median EBL: mL (range) | 250 (10–4000) |
No. of visceral resections: median (range) | 2 (0–10) |
No. of anastomoses: median (range) | 1 (0–6) |
CC score | |
0 | 199 (80.6) |
1 | 36 (14.6) |
2 | 11 (4.5) |
3 | 1 (0.04) |
Median LOS: days (range) | 10 (4–45) |
BMI Body mass index, CCI Charlson comorbidity index, ASA American Society of Anesthesiology classification of physical health, NA not available, CEA carcinoembryonic antigen, PCI peritoneal cancer index, CRS-HIPEC cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, EBL estimated blood loss, CC completeness of cytoreduction, LOS hospital length of stay